Pharmacokinetics of a Novel Trioxane Antimalarial Drug 99/411: Alterations Upon Rifampicin Coadministration, Single and Multiple Oral Dose Drug–Drug Interactions in Sprague-Dawley Rats
International Journal of Pharmacokinetics · 2017
DOI: 10.4155/ipk-2017-0001 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmacokinetics, 2017. Verfasst von Mahendra Kumar Hidau und 2 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Gefördert von: CSIR-CDRI, Council for Scientific and Industrial Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- CSIR-CDRI
- Council for Scientific and Industrial Research
Zitieren
APA
Hidau, M. K., Singh, Y., & Singh, S. K. (2017). Pharmacokinetics of a Novel Trioxane Antimalarial Drug 99/411: Alterations Upon Rifampicin Coadministration, Single and Multiple Oral Dose Drug–Drug Interactions in Sprague-Dawley Rats. International Journal of Pharmacokinetics. https://doi.org/10.4155/ipk-2017-0001
Vancouver
Hidau MK, Singh Y, Singh SK. Pharmacokinetics of a Novel Trioxane Antimalarial Drug 99/411: Alterations Upon Rifampicin Coadministration, Single and Multiple Oral Dose Drug–Drug Interactions in Sprague-Dawley Rats. International Journal of Pharmacokinetics. 2017. doi:10.4155/ipk-2017-0001
BibTeX
@article{Hidau2017,
author = {Hidau, Mahendra Kumar and Singh, Yeshwant and Singh, Shio Kumar},
title = {Pharmacokinetics of a Novel Trioxane Antimalarial Drug 99/411: Alterations Upon Rifampicin Coadministration, Single and Multiple Oral Dose Drug–Drug Interactions in Sprague-Dawley Rats},
journal = {International Journal of Pharmacokinetics},
year = {2017},
doi = {10.4155/ipk-2017-0001}
}
EUVIMED